BioSpace News Archive

Cerner Corporation (Nasdaq: CERN) today announced it will release its first quarter 2021 earnings results before the market opens Wednesday, May 5th

Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the Tilray board of directors approved an amendment to the Company’s bylaws to reduce the quorum requirement for shareholder meetings

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs™), today announced that preclinical data for their lead candidate, AOC 1001 in development for myotonic dystrophy type 1 (DM1), will be presented at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 6, 2021 to reports its first quarter 2021 financial results, and provide a corporate update.

According to the report, the global pain management therapeutics market was valued at US$ 66.6 Bn in 2018 and is anticipated to expand at a CAGR of 3.7% from 2019 to 2027

According to the report, the global parenteral nutrition market was valued at US$ 5.6 Bn in 2018 and is anticipated to grow at a CAGR of 4.6% from 2019 to 2027

The advanced wound care market is predicted to display steadfast growth over the forecast period from 2020 to 2030.

The increasing cases of infectious diseases are a prime factor augmenting the growth of the global digital PCR and real-time PCR market during the forecast period set between 2020 and2030.

The drive for monitoring antimicrobial resistance in agricultural settings by public health policy makers in various countries is a key trend in the expansion of the veterinary antimicrobial susceptibility testing market.

Relay Therapeutics’ leadership in this new breed of biotech positions the company as a strategic partner of choice for emerging technologies and founders in these fields